ICAD INC (ICAD) Stock Price, Forecast & Analysis
NASDAQ:ICAD • US44934S2068
ICAD Key Statistics, Chart & Performance
The current stock price of ICAD is 3.87 USD. In the past month the price increased by 1.04%. In the past year, price increased by 197.69%.
ICAD Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ICAD. When comparing the yearly performance of all stocks, ICAD is one of the better performing stocks in the market, outperforming 97.09% of all stocks.
ICAD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ICAD. While ICAD has a great health rating, there are worries on its profitability.
ICAD Financial Highlights
Over the last trailing twelve months ICAD reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -50% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.24% | ||
| ROE | -16.98% | ||
| Debt/Equity | 0 |
ICAD Forecast & Estimates
10 analysts have analysed ICAD and the average price target is 3.57 USD. This implies a price decrease of -7.75% is expected in the next year compared to the current price of 3.87.
For the next year, analysts expect an EPS growth of 12.57% and a revenue growth 4.66% for ICAD
ICAD Ownership
ICAD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 20.78 | 29.919B | ||
| WAY | WAYSTAR HOLDING CORP | 15.53 | 4.907B | ||
| DOCS | DOXIMITY INC-CLASS A | 14.01 | 4.531B | ||
| HTFL | HEARTFLOW INC | N/A | 1.972B | ||
| CERT | CERTARA INC | 12.75 | 1.128B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.097B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 228.65 | 1.088B | ||
| TDOC | TELADOC HEALTH INC | N/A | 932.861M | ||
| SDGR | SCHRODINGER INC | N/A | 888.34M | ||
| PHR | PHREESIA INC | 18.88 | 743.376M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ICAD
Company Profile
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 66 full-time employees. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a two-dimensional or three-dimensional mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting and algorithmically examining.
Company Info
ICAD INC
98 Spit Brook Rd Ste 100
Nashua NEW HAMPSHIRE 03062 US
CEO: Michael Klein
Employees: 66
Phone: 16038825200
ICAD INC / ICAD FAQ
What does ICAD INC do?
iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 66 full-time employees. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a two-dimensional or three-dimensional mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting and algorithmically examining.
What is the stock price of ICAD INC today?
The current stock price of ICAD is 3.87 USD. The price increased by 3.75% in the last trading session.
Does ICAD INC pay dividends?
ICAD does not pay a dividend.
What is the ChartMill rating of ICAD INC stock?
ICAD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What do analysts say about ICAD INC (ICAD) stock?
10 analysts have analysed ICAD and the average price target is 3.57 USD. This implies a price decrease of -7.75% is expected in the next year compared to the current price of 3.87.
How many employees does ICAD INC have?
ICAD INC (ICAD) currently has 66 employees.